Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

WeightRx vs CoreAge Rx

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
WeightRx logo

WeightRx

6.8
★★★☆☆3.4/5

Best for: bloodwork inside the monthly price rather than billed on top

Visit WeightRx
VS
CoreAge Rx logo

CoreAge Rx

9.1
★★★★4.6/5

Best for: semaglutide at $99/month, 48% under the register median

Visit CoreAge Rx

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, WeightRx opens cheaper — $83/mo against $99, and CoreAge Rx finishes ahead, 9.1 to 6.8. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

WeightRx

StartingCompounded
$83/mo
semaglutide
StartingCompounded
$83/mo
tirzepatide

Tirzepatide $83/mo (semaglutide $250/mo); both shown on homepage

CoreAge Rx

Injectable, monthly auto-refill (flat across all dosages)Compounded
$99/mo
semaglutide

Re-verified 2026-08-05: homepage + Preventive Longevity section both show "Semaglutide — Starting at $99/mo", "Same price at every dose"; supersedes stale tiered pricing captured 2026-06-05.

Injectable, monthly auto-refill (flat across all dosages)Compounded
$149/mo
tirzepatide

Re-verified 2026-08-05: homepage GLP-1 hero + Preventive Longevity section both show "Tirzepatide — Starting at $149/mo", "Same price at every dose"; supersedes stale tiered pricing captured 2026-06-05.

What’s included

WeightRx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

In the price

Coaching

Not stated

CoreAge Rx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

WeightRx

6.8/10

Overall

CoreAge Rx

9.1/10

Value25%

3.0A
vs
B
9.7

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
8.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

8.5A
vs
B
7.0

Features & Coverage

FeatureWeightRxCoreAge Rx
Starting Price$83/mo$99/mo
Features2 features6 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

About WeightRx

Few telehealth sellers charge less per month for compounded semaglutide than WeightRx does.

Read our full WeightRx review →

About CoreAge Rx

Shipping is free, 2-day, and reaches all 50 states. CoreAge Rx sells LegitScript-verified compounded semaglutide plus tirzepatide, with licensed physicians behind it and 24/7 support. Its own claim: nobody in the compounded GLP-1 space prices more competitively.

Read our full CoreAge Rx review →

Pros & Cons

WeightRx

What we like

  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, shipping, labs
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

CoreAge Rx

What we like

  • Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
  • Tirzepatide at $149 a month, 44% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: CoreAge Rx

CoreAge Rx takes it, 9.1 against 6.8, and it is especially strong on semaglutide at $99/month, 48% under the register median. WeightRx is no weak second and may fit you better on bloodwork inside the monthly price rather than billed on top.

Choose WeightRx if…

You want bloodwork inside the monthly price rather than billed on top and an opening price near $83 a month.

Choose CoreAge Rx if…

You want semaglutide at $99/month, 48% under the register median and an opening price near $99 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.3

Telos Rx

Starting below a standard dose, with microdose tiers

7.0

MyDrHank

An oral route if you will not self-inject

6.0

SkinnyRx

Starting below a standard dose, with microdose tiers

WeightRx vs CoreAge Rx: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring WeightRx and CoreAge Rx head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.